Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph J DeGeorge

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Regulatory Toxicology and Pharmacology : RTP|November 3, 2016
Role of chronic toxicology studies in revealing new toxicitiesAlema Galijatovic-Idrizbegovic, Judith E Miller, Wendy D Cornell, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2016
Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogsChristopher P Regan, Gary L Stump, Theodore J Detwiler, et al.
Regulatory Toxicology and Pharmacology : RTP|May 10, 2017
Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspectiveLynne D Butler, Peggy Guzzie-Peck, James Hartke, et al.
Hepatology (Baltimore, Md.)|July 31, 2016
Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeysChristopher P Regan, Pierre Morissette, Hillary K Regan, et al.
Regulatory Toxicology and Pharmacology : RTP|April 15, 2019
Analysis of exposure margins in developmental toxicity studies for detection of human teratogensPaul A Andrews, Diann Blanset, Priscila Lemos Costa, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Regulatory Toxicology and Pharmacology : RTP|November 3, 2016
Role of chronic toxicology studies in revealing new toxicitiesAlema Galijatovic-Idrizbegovic, Judith E Miller, Wendy D Cornell, et al.
Journal of Pharmacological and Toxicological Methods|May 12, 2016
Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogsChristopher P Regan, Gary L Stump, Theodore J Detwiler, et al.
Regulatory Toxicology and Pharmacology : RTP|May 10, 2017
Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspectiveLynne D Butler, Peggy Guzzie-Peck, James Hartke, et al.
Hepatology (Baltimore, Md.)|July 31, 2016
Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeysChristopher P Regan, Pierre Morissette, Hillary K Regan, et al.
Regulatory Toxicology and Pharmacology : RTP|April 15, 2019
Analysis of exposure margins in developmental toxicity studies for detection of human teratogensPaul A Andrews, Diann Blanset, Priscila Lemos Costa, et al.
Toxicologic Pathology|June 14, 2011
An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelinesFrank D Sistare, Daniel Morton, Carl Alden, et al.
Pageof 2